These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33240859)

  • 1. Moving Beyond the Pillars of Cancer Treatment: Perspectives From Nanotechnology.
    Siamof CM; Goel S; Cai W
    Front Chem; 2020; 8():598100. PubMed ID: 33240859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Nanotechnology into Cancer Care.
    Grodzinski P; Kircher M; Goldberg M; Gabizon A
    ACS Nano; 2019 Jul; 13(7):7370-7376. PubMed ID: 31240914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress of Conjugated Nanomedicine for Cancer Treatment.
    Zhao B; Chen S; Hong Y; Jia L; Zhou Y; He X; Wang Y; Tian Z; Yang Z; Gao D
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.
    Hartshorn CM; Bradbury MS; Lanza GM; Nel AE; Rao J; Wang AZ; Wiesner UB; Yang L; Grodzinski P
    ACS Nano; 2018 Jan; 12(1):24-43. PubMed ID: 29257865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects.
    Zhang P; Xiao Y; Sun X; Lin X; Koo S; Yaremenko AV; Qin D; Kong N; Farokhzad OC; Tao W
    Med; 2023 Mar; 4(3):147-167. PubMed ID: 36549297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.
    Chakraborty K; Tripathi A; Mishra S; Mallick AM; Roy RS
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35638450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology in the arena of cancer immunotherapy.
    Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
    Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.
    Falagan-Lotsch P; Grzincic EM; Murphy CJ
    Bioconjug Chem; 2017 Jan; 28(1):135-152. PubMed ID: 27973767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs.
    Ahmed T; Liu FF; Lu B; Lip H; Park E; Alradwan I; Liu JF; He C; Zetrini A; Zhang T; Ghavaminejad A; Rauth AM; Henderson JT; Wu XY
    Mol Pharm; 2022 Jun; 19(6):1722-1765. PubMed ID: 35587783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Incorporated Nanomedicines for Cancer Therapy.
    Wu SY; Wu FG; Chen X
    Adv Mater; 2022 Jun; 34(24):e2109210. PubMed ID: 35142395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Gold Nanoparticle-Based Combined Cancer Therapy.
    Bromma K; Chithrani DB
    Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32858957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging.
    Ouyang J; Xie A; Zhou J; Liu R; Wang L; Liu H; Kong N; Tao W
    Chem Soc Rev; 2022 Jun; 51(12):4996-5041. PubMed ID: 35616098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology as a tool to overcome macromolecules delivery issues.
    Tundisi LL; Ataide JA; Costa JSR; Coêlho DF; Liszbinski RB; Lopes AM; Oliveira-Nascimento L; de Jesus MB; Jozala AF; Ehrhardt C; Mazzola PG
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113043. PubMed ID: 36455361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
    Cheng CT; Castro G; Liu CH; Lau P
    Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.